Conclusions The combination of bevacizumab and erlotinib showed antitumor activity in patients with HLRCC-associated or sporadic papillary renal-cell carcinoma.

This is a study looking for genes that may increase the risk of getting a type of kidney cancer called papillary renal cell cancer.

Papillary renal cell carcinoma (PRCC) is a type of cancer that forms inside the lining of the kidney tubules. Learn more about the signs and treatments.

Hereditary papillary kidney cancer is a genetic syndrome that may increase the risk of a person developing type one papillary kidney cancer. Learn more here.

On three occasions, a 26-year-old woman suffered significant injuries after undergoing hair-straightening treatments at a salon. According to her doctors, it was the products used. The three ...

Clear cell papillary renal cell carcinoma is a type of kidney cancer. Healthcare professionals now refer to it as clear cell papillary renal cell tumor.

Read on to learn about the symptoms of duodenal ulcers, their most common causes and complications, and how a duodenal ulcer can be diagnosed and treated.

Novel Combinations for Papillary Renal Cancer – MET and PDL-1 inhibitors tested in patients with MET-driven tumors ...

Treatment with an investigational MET inhibitor plus a PD-L1 inhibitor induced responses in fewer than a third of patients with metastatic papillary renal cancer, but the combination showed ...

Investigators examined the natural history of papillary renal cell carcinoma (RCC) type I vs type II and oncologic outcomes.

Adults undergoing heart surgery who take heartburn medication before the procedure are more likely to develop acute kidney injury and to die during hospitalization, a study found.

Cabozantinib conferred a significant and meaningful extension of PFS compared with sunitinib in metastatic papillary renal cell carcinoma, according to results of a phase 2 randomized trial ...